Insider Transactions in Q3 2024 at Centessa Pharmaceuticals PLC (CNTA)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 10
2024
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
175,000
-18.38%
|
$2,800,000
$16.52 P/Share
|
Sep 10
2024
|
Saurabh Saha Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
175,000
+15.53%
|
$875,000
$5.84 P/Share
|
Sep 10
2024
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
30,000
-11.84%
|
$510,000
$17.0 P/Share
|
Sep 10
2024
|
Gregory M Weinhoff Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+10.59%
|
$150,000
$5.84 P/Share
|
Sep 09
2024
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
25,000
-10.07%
|
$375,000
$15.0 P/Share
|
Sep 09
2024
|
Gregory M Weinhoff Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+9.15%
|
$125,000
$5.84 P/Share
|
Aug 23
2024
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
17,802
-7.38%
|
$213,624
$12.29 P/Share
|
Aug 23
2024
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
46,651
-5.66%
|
$559,812
$12.3 P/Share
|
Aug 22
2024
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
12,198
-4.81%
|
$146,376
$12.17 P/Share
|
Aug 22
2024
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
506
-0.06%
|
$6,072
$12.23 P/Share
|
Aug 21
2024
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,674
-0.44%
|
$44,088
$12.25 P/Share
|
Aug 20
2024
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,169
-0.5%
|
$50,028
$12.32 P/Share
|